Masakazu Atobe

649 total citations
25 papers, 509 citations indexed

About

Masakazu Atobe is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Masakazu Atobe has authored 25 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Masakazu Atobe's work include Chemical Synthesis and Analysis (6 papers), Synthetic Organic Chemistry Methods (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Masakazu Atobe is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Synthetic Organic Chemistry Methods (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Masakazu Atobe collaborates with scholars based in Japan, United Kingdom and Germany. Masakazu Atobe's co-authors include Naoki Yamazaki, Chihiro Kibayashi, Masashi Kawanishi, Masahiro Fujii, Hiroko Suzuki, Peter O’Brien, Roderick E. Hubbard, Paul S. Bond, James D. Firth and Yoshitaro Nose and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Masakazu Atobe

24 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masakazu Atobe Japan 14 270 183 79 76 52 25 509
J.O. Daiss Germany 12 272 1.0× 136 0.7× 13 0.2× 21 0.3× 75 1.4× 20 431
Kristy Tran United States 13 303 1.1× 100 0.5× 76 1.0× 9 0.1× 105 2.0× 14 475
Laurie B. Schenkel United States 13 390 1.4× 125 0.7× 12 0.2× 27 0.4× 99 1.9× 24 582
Swapan Majumdar India 14 331 1.2× 115 0.6× 26 0.3× 54 0.7× 42 0.8× 36 475
Seong Jun Park South Korea 14 344 1.3× 202 1.1× 13 0.2× 10 0.1× 34 0.7× 30 543
Takashi Kamikubo Japan 15 343 1.3× 119 0.7× 96 1.2× 171 2.3× 32 0.6× 60 602
Seiko Fujii United States 3 318 1.2× 138 0.8× 138 1.7× 39 0.5× 36 0.7× 3 528
Kathy Sarris United States 13 313 1.2× 213 1.2× 49 0.6× 7 0.1× 26 0.5× 18 515
Jonathan W. Lehmann United States 4 351 1.3× 162 0.9× 144 1.8× 46 0.6× 54 1.0× 4 585
Andrea M. E. Palazzolo Ray United States 2 279 1.0× 145 0.8× 156 2.0× 46 0.6× 41 0.8× 2 517

Countries citing papers authored by Masakazu Atobe

Since Specialization
Citations

This map shows the geographic impact of Masakazu Atobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Atobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Atobe more than expected).

Fields of papers citing papers by Masakazu Atobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Atobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Atobe. The network helps show where Masakazu Atobe may publish in the future.

Co-authorship network of co-authors of Masakazu Atobe

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Atobe. A scholar is included among the top collaborators of Masakazu Atobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Atobe. Masakazu Atobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atobe, Masakazu, et al.. (2023). α‐Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping. Angewandte Chemie. 136(2).
2.
Atobe, Masakazu, et al.. (2023). α‐Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping. Angewandte Chemie International Edition. 63(2). e202314423–e202314423. 5 indexed citations
3.
Jones, Simon, James D. Firth, Masakazu Atobe, et al.. (2022). Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinates. RSC Medicinal Chemistry. 13(12). 1614–1620. 4 indexed citations
4.
Downes, Thomas D., Simon Jones, Hanna F. Klein, et al.. (2020). Design and Synthesis of 56 Shape‐Diverse 3D Fragments. Chemistry - A European Journal. 26(41). 8969–8975. 39 indexed citations
5.
Atobe, Masakazu, Masashi Kawanishi, Takahiko Hayashi, et al.. (2018). Discovery of a novel 2-(1H-pyrazolo[3,4-b]pyridin-1-yl)thiazole derivative as an EP1 receptor antagonist and in vivo studies in a bone fracture model. Bioorganic & Medicinal Chemistry Letters. 28(14). 2408–2412. 4 indexed citations
6.
Atobe, Masakazu, James D. Firth, Paul S. Bond, et al.. (2017). Increase of enzyme activity through specific covalent modification with fragments. Chemical Science. 8(11). 7772–7779. 33 indexed citations
7.
Atobe, Masakazu, Yasuhiro Wada, Tokuhito Goto, et al.. (2017). A series of novel indazole derivatives of Sirt 1 activator as osteogenic regulators. Bioorganic & Medicinal Chemistry Letters. 27(21). 4828–4831. 5 indexed citations
8.
Lüthy, Monique, Masakazu Atobe, Paul S. Bond, et al.. (2015). Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library. Bioorganic & Medicinal Chemistry. 23(11). 2680–2694. 21 indexed citations
9.
Atobe, Masakazu, Masashi Kawanishi, K. Kasahara, et al.. (2014). Discovery of 2-(1H-indazol-1-yl)-thiazole derivatives as selective EP1 receptor antagonists for treatment of overactive bladder by core structure replacement. Bioorganic & Medicinal Chemistry Letters. 24(5). 1327–1333. 18 indexed citations
10.
Atobe, Masakazu, Masashi Kawanishi, K. Kasahara, et al.. (2013). Hit-to-lead optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as a novel class of EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(22). 6064–6067. 17 indexed citations
11.
Atobe, Masakazu, et al.. (2013). Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 2111–2116. 6 indexed citations
12.
Atobe, Masakazu, et al.. (2013). A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 2106–2110. 12 indexed citations
13.
Atobe, Masakazu, Masashi Kawanishi, K. Kasahara, et al.. (2013). SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(24). 6569–6576. 18 indexed citations
14.
Atobe, Masakazu, et al.. (2013). Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping. European Journal of Medicinal Chemistry. 71. 250–258. 15 indexed citations
15.
Atobe, Masakazu, Naoki Yamazaki, & Chihiro Kibayashi. (2005). Asymmetric synthesis of (+)-abresoline. Tetrahedron Letters. 46(15). 2669–2673. 21 indexed citations
16.
17.
Takai, Madoka, et al.. (2004). Pico liter dispenser with 128 independent nozzles for high throughput biochip fabrication. 276–279. 11 indexed citations
18.
Yamazaki, Naoki, Masakazu Atobe, & Chihiro Kibayashi. (2002). Enantioselective synthesis of NK-1 receptor antagonists (+)-CP-99,994 and (+)-CP-122,721. Tetrahedron Letters. 43(44). 7979–7982. 34 indexed citations
19.
Nose, Yoshitaro, et al.. (2002). A low power, small, electrostatically-driven commercial inkjet head. 63–68. 47 indexed citations
20.
Fujii, Masahiro, et al.. (2002). A high resolution, electrostatically-driven commercial inkjet head. 793–798. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026